David Vaughn, MD

Abramson Cancer Center of The ...Philadelphia, Pennsylvania - 19104 (215-662-2812) University of PennsylvaniaPhiladelphia, Pennsylvania - 19104 (215-746-7144) Alexandria, Minnesota - 56308 (320-229-4907) University of Pennsylvania:Abramson Cancer CenterPhiladelphia, Pennsylvania - 19104 |
- CLINICAL TRIALS 5
- CONDITIONS6
- INTERVENTIONS6
- SINCE2006

Trial of Maintenance SU011248 Versus Placebo Post Chemotherapy Patients With Advanced Urothelial Carcinoma
February 2010 - February 2013

Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors
December 2007 - December 2009

ARQ 197 for Subjects With Relapsed or Refractory Germ Cell Tumors
January 2010 - January 2012

Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients
October 2006 - November 2012

Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma
May 2006 - June 2015
Neoplasms
Urinary Bladder Neoplasms
Carcinoma
Neoplasms, Germ Cell and Embryonal
Carcinoma, Transitional Cell
Seminoma
Placebo
Aprepitant
Su011248
Sutent
Arq 197
Bevacizumab And Oxaliplatin



